Nina Anseeuw

Nina Anseeuw

Auto-generated profile, based on publicly available information

Nina Anseeuw

Molecular Imaging and Photonics Department of Chemistry KU Leuven Leuven Belgium

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
NANina Anseeuw
Nina Anseeuw
CECarmen Escalona-Noguero
Carmen Escalona-Noguero
GVGiel Vankevelaer
Giel Vankevelaer
OWOlivier De Wever
Olivier De Wever
IEIlaria Elia
Ilaria Elia
GFGuillermo Solis Fernandez
Guillermo Solis Fernandez
Cancer-associated fibroblasts (CAFs) are key regulators of tumor progression, yet their activation state is commonly assessed using static, endpoint assays that do not allow dynamic analysis in living cells. Although CAF activation is accompanied by pronounced metabolic remodeling, label-free approaches that exploit these changes for real-time monitoring remain limited. Here, we demonstrate that NADH fluorescence lifetime imaging microscopy (FLIM) provides a non-invasive readout of this process. CAFs activated with transforming growth factor beta (TGF-β) exhibit a reproducible shift toward longer NADH fluorescence lifetimes compared to non-activated cells, consistent with changes in the relative contributions of free and protein-bound NADH. By combining live-cell FLIM with α-smooth muscle actin staining in the same cells, we directly link metabolic signatures to cellular activation state. We further demonstrate the potential of this approach to dynamically monitor CAF activation in live, migrating cells. Together, these results establish NADH fluorescence lifetime imaging as a label-free metabolic approach for monitoring CAF activation dynamics, complementing conventional marker-based methods and enabling continuous monitoring of tumor-stroma interactions.

28 July 2026 in ChemBioChem
Verified
Journal Article
Open access
PDF file
NANina Anseeuw
Nina Anseeuw
CECarmen Escalona‐Noguero
Carmen Escalona‐Noguero
GVGiel Vankevelaer
Giel Vankevelaer
SASamet Aytekin
Samet Aytekin
OWOlivier De Wever
Olivier De Wever
GFGuillermo Solis Fernandez
Guillermo Solis Fernandez
Cancer‐associated fibroblasts (CAFs) are key regulators of tumor progression, yet their activation state is commonly assessed using static, endpoint assays that do not allow dynamic analysis in living cells. Although CAF activation is accompanied by pronounced metabolic remodeling, label‐free approaches that exploit these changes for real‐time monitoring remain limited. Here, we demonstrate that NAD(P)H fluorescence lifetime imaging microscopy (FLIM) can be used to monitor activation‐associated metabolic remodeling. CAFs activated with transforming growth factor beta (TGF‐β) exhibit a reproducible shift toward longer NAD(P)H fluorescence lifetimes compared to non‐activated cells, consistent with changes in the relative contributions of free and protein‐bound NAD(P)H. By combining live‐cell FLIM with α‐smooth muscle actin staining in the same cells, we directly link metabolic signatures to cellular activation state. We further demonstrate the potential of this approach to dynamically monitor CAF activation in live, migrating cells. Together, these results establish NAD(P)H fluorescence lifetime imaging as a label‐free metabolic approach for monitoring CAF activation dynamics, complementing conventional marker‐based methods and enabling continuous monitoring of tumor–stroma interactions.